← Open Payments lookup

ANGELA ROMANO: Open Payments

NPI 1487810537 · WARSAW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,521 in 68 payments from 14 companies in 2025. Trend: 2023 $47 · 2024 $2,502 · 2025 $1,521

Food & beverage: $1,514Education: $8
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.8$248
Teva Pharmaceuticals USA, Inc.11$246
Alkermes, Inc.14$229
Janssen Pharmaceuticals, Inc9$217
Otsuka America Pharmaceutical, Inc.13$209
Tris Pharma Inc1$124
Takeda Pharmaceuticals U.S.A., Inc.3$62
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$61
Neurocrine BioSciences, Inc.1$26
HARMONY BIOSCIENCES LLC1$24

Products named: COBENFY, ARISTADA, UZEDY, INVEGA SUSTENNA, REXULTI, Dyanavel XR, AUSTEDO XR, TRINTELLIX.

Industry payments across IN — which companies pay providers there.